Nieuws

BREAKFAST SEMINAR "THE ACQUISITION PROCESS IN A NUTSHELL"

Ambos NBGO Lawyers organises in collaboration with Vandelanotte Corporate Finance and ING Bank a breakfast seminar on the sale and purchase of small and medium sized companies.

While you enjoy your breakfast, a lawyer, an accountant and a banker will guide you through the acquisition process, discuss certain important topics and will you be offered the opportunity to ask questions.

AMBOS NBGO ASSISTED THROMBOGENICS IN THE WORLDWIDE BIOTECHDEAL OF 2012

The leading Belgian biotech company, Thrombogenics, was honored with the Scrip Award for the "Best Licensing Agreement of 2012" worldwide in the biotech sector. Scrip Awards are the most prestigious international awards in the biotech sector.

5 DECEMBER 2012 - LUNCH SEMINAR: MANDATORY ACCESS AND PRODUCTION OF DOCUMENTS AND INFORMATION IN CIVIL AND IN CRIMINAL MATTERS

Speakers: Carl Bevernage, Peter Van de Vijver

Language: NL, FR

Location and time: Ambos NBGO Brussels, 12.00 - 14.00 PM

26 NOVEMBER 2012 - BREAKFAST SEMINAR : ALTERNATIVE STRUCTURES FOR THE PURCHASE OR SALE OF REAL ESTATE

Speakers: Christina Trappeniers, Stijn Verbeke, Filip De Schouwer

Languages: NL, FR

Location and time: Ambos NBGO Brussels, 8.00 – 10.00 pm
 

FALSE SELF-EMPLOYMENT ACT MODIFIED .....ONCE AGAIN

In its battle against social and tax fraud the legislator has modified the Act on Labour Relationships (1).

Three important modifications have been made:
 

AMBOS NBGO ASSISTS IDEALABS WITH SET-UP OF NEW INNOVATIVE FUND STRUCTURE

Ambos NBGO advises and assists Idealabs with the set–up of an innovative fund structure that will operate as one of the first Belgian seed accelerator programs.

On Assignment acquires Valesta

Ambos NBGO has assisted On Assignment, Inc., a US based provider of professionals in the life sciences, healthcare and technology sectors, with the preparation, negotiation and completion of its acquisition of the Valesta group, a privately owned provider of specialized staffing in the area of clinical research within Western Europe.

Ambos NBGO assists ThromboGenics in its Commercialization/Licensing Agreement for Ocriplasmin with Alcon/Novartis

Ambos NBGO has assisted ThromboGenics (www.thrombogenics.com) with the preparation and organization of its auction procedure and with the subsequent preparation, negotiation and execution of the Commercialization/Licensing Agreement entered into with Alcon/Novartis for the product Ocriplasmin.

Ambos NBGO assisted ThromboGenics in its auction procedure and subsequent signing of its Commercialization/Licensing Agreement for Ocriplasmin with Alcon/Novartis for Europe and non-US Rest-of-World

Ambos NBGO has assisted ThromboGenics with the preparation and organization of its auction procedure and with the subsequent preparation, negotiation and execution of the Commercialization/Licensing Agreement entered into with Alcon/Novartis for the product Ocriplasmin. This licensing agreement covers Europe and all other countries worldwide except the USA (www.alcon.com and www.novartis.com). 

BEST REGIONAL LAW FIRM IN FLANDERS 2010

Pages